U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579949) titled 'A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)' on April 23.
Brief Summary: This study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.
Study Start Date: June 18
Study Type: INTERVENTIONAL
Condition:
Thalassemia
Intervention:
DRUG: SNH-119014 dose 1
Study Drug
DRUG: SNH-119014 dose 2
Study Drug
DRUG: Placebo
Placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor:...